Overview

Effect of Dosing Time and Meal on IN-105 (Insulin Tregopil) PK and PD

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
A study to evaluate the PK and PD of oral IN-105 (Insulin Tregopil) w.r.t. time of dosing prior to meal, duration between meals and type of meal .
Phase:
Phase 1
Details
Lead Sponsor:
Biocon Limited
Treatments:
Insulin